CJC – 1295 no DAC (5mg)

$75.00

● In Stock
Ready to Ship

Description

CJC-1295 No DAC is a synthetic peptide commonly studied in laboratory research involving growth hormone-releasing hormone (GHRH) receptor signalling and growth hormone secretion pathways. The No DAC form is researched for its shorter-acting activity compared with DAC-modified variants.

Research & Laboratory Use Only

CJC-1295 no DAC is supplied by AusiGen strictly for controlled laboratory research, analytical testing and non-clinical scientific investigation only.

Not intended for human or veterinary use. By purchasing, you confirm that you are a qualified researcher and will handle and use this compound in accordance with all applicable laws, regulations and laboratory requirements.

Key Research Areas

GHRH Receptor Research — for non-clinical studies examining growth hormone-releasing hormone receptor activity and associated signalling pathways.
Growth Hormone Signalling Studies — used in controlled laboratory research investigating peptide-mediated growth hormone signalling and response mechanisms.
GH/IGF-1 Pathway Research — suitable for analytical studies examining growth hormone signalling and downstream insulin-like growth factor pathways.
Pituitary Response Research — for laboratory investigation of GHRH-related signalling within controlled anterior pituitary model systems.
Short-Acting Peptide Research — applicable to studies examining transient peptide activity, degradation and time-dependent signalling behaviour.
Receptor Interaction Analysis — used in non-clinical research evaluating peptide-receptor binding, activation and downstream cellular responses.
Peptide Stability Studies — suitable for controlled investigation of peptide stability, breakdown and analytical behaviour under laboratory conditions.
Molecular Reference Work — applicable for compound identification, analytical comparison and laboratory research documentation.